Chapter 12. Lipids and Cardiovascular Disease

  1. Salim Yusuf1,
  2. John A Cairns2,
  3. A John Camm3,
  4. Ernest L Fallen4 and
  5. Bernard J Gersh5
  1. Malcolm Law

Published Online: 4 OCT 2007

DOI: 10.1002/9780470986882.ch12

Evidence-based Cardiology, Second Edition

Evidence-based Cardiology, Second Edition

How to Cite

Law, M. (2002) Lipids and Cardiovascular Disease, in Evidence-based Cardiology, Second Edition (eds S. Yusuf, J. A. Cairns, A. J. Camm, E. L. Fallen and B. J. Gersh), BMJ Books, London, UK. doi: 10.1002/9780470986882.ch12

Editor Information

  1. 1

    Heart and Stroke Foundation of Ontario Research Chair, Senior Scientist of the Canadian Institute of Health Research, Director of Cardiology and Professor of Medicine, McMaster, University, Hamilton Health Sciences, Hamilton, Canada

  2. 2

    Dean, Faculty of Medicine, University of British Columbia, Vancouver, Canada

  3. 3

    Professor of Clinical Cardiology and Chief, Department of Cardiological Sciences, St George's Hospital Medical School, London, UK

  4. 4

    Professor Emeritus, McMaster University, Faculty of Health Sciences, Hamilton, Canada

  5. 5

    Consultant in Cardiovascular Diseases and Internal Medicine, Mayo Clinic; Professor of Medicine, Mayo Medical School, Rochester, Minnesota, USA

Publication History

  1. Published Online: 4 OCT 2007
  2. Published Print: 20 NOV 2002

ISBN Information

Print ISBN: 9780727916990

Online ISBN: 9780470986882

SEARCH

Keywords:

  • lipids;
  • cardiovascular disease;
  • lipoprotein cholesterols;
  • ischemic heart disease;
  • serum cholesterol

Summary

This chapter contains sections titled:

  • Serum total and low density lipoprotein cholestero

  • Serum cholesterol and ischemic heart disease

  • Dietary fat and serum cholesterol

  • Serum cholesterol and circulatory diseases other than ischemic heart disease

  • Safety of cholesterol reduction

  • Why was cholesterol reduction contentious?

  • Dietary fat and coagulation

  • Triglycerides

  • High density lipoprotein cholesterol

  • Lipids as screening tests

  • Appropriate policy

  • Conclusions